0000899243-22-015542.txt : 20220425 0000899243-22-015542.hdr.sgml : 20220425 20220425121203 ACCESSION NUMBER: 0000899243-22-015542 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220421 FILED AS OF DATE: 20220425 DATE AS OF CHANGE: 20220425 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chin Mark CENTRAL INDEX KEY: 0001734389 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40881 FILM NUMBER: 22848447 MAIL ADDRESS: STREET 1: 20 BERKELEY SQUARE, MAYFAIR CITY: LONDON STATE: X0 ZIP: W1J 6EQ ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pyxis Oncology, Inc. CENTRAL INDEX KEY: 0001782223 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831160910 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: (617) 221-9059 MAIL ADDRESS: STREET 1: 35 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-04-21 1 0001782223 Pyxis Oncology, Inc. PYXS 0001734389 Chin Mark C/O PYXIS ONGOLOCY, INC. 35 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 0 0 0 1 Former Director Common Stock 2022-04-21 4 S 0 1745761 3.05 D 0 I See footnote The securities were held directly by Arix Bioscience Holdings Limited ("Arix"). The Reporting Person is one of for members of the Investment Committee of Arix and, in such capacity, may be deemed to share voting and dispositive power over the securities held by Arix. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his respective pecuniary interests therein. /s/ Mark Chin 2022-04-25